News

Key news

picture of article

PRESS-RELEASE

OncoDNA announces expansion of its services into the United States

Jan. 7, 2021Read more

picture of article

PRESS-RELEASE

OncoDNA announces expansion of its services into the United States

Jan. 7, 2021Read more

picture of article

PRESS-RELEASE

OncoDNA wins the Biotech Award of Deloitte’s 2020 Technology Fast50 competition

Nov. 27, 2020Read more

picture of article

PRESS-RELEASE

New Molecular Diagnostic Innovation Partnership to facilitate patient access to personalised cancer care across the UK

Nov. 24, 2020Read more

All news

- OncoDNA announces expansion of its services into the United States
- Jan. 7, 2021
- read more
- OncoDNA wins the Biotech Award of Deloitte’s 2020 Technology Fast50 competition
- Nov. 27, 2020
- read more
- New Molecular Diagnostic Innovation Partnership to facilitate patient access to personalised cancer care across the UK
- Nov. 24, 2020
- read more
- Succès de l’offre publique d’achat amicale initiée par OncoDNA sur les actions IntegraGen
- Nov. 17, 2020
- read more
- Successful Friendly Takeover Bid Initiated by OncoDNA on IntegraGen’shares
- Nov. 17, 2020
- read more
- OncoDNA has been nominated for the Deloitte’s 2020 Technology Fast 50
- Nov. 10, 2020
- read more
- American Hospital of Paris and OncoDNA Partner to Advance Breast Cancer Patients Management
- Oct. 13, 2020
- read more
- OncoDNA Signs Collaboration Agreement with the European Cancer Patient Coalition on the 2020 Personalised Medicine Awareness Project
- Sept. 24, 2020
- read more
- OncoKDM® Used as the Support SaaS Platform in a Prospective Pilot Study of Veneto Institute of Oncology – IRCCS
- Sept. 10, 2020
- read more
- OncoDNA has been nominated for the 2020 BVA Award Growth Company of the Year
- Sept. 8, 2020
- read more
- ONCODNA provides an update about the friendly takeover bid on INTEGRAGEN
- Aug. 12, 2020
- read more
- ONCODNA fait un point à propos de l’offre publique d’achat amicale sur INTEGRAGEN
- Aug. 12, 2020
- read more
- OncoDNA extends its Clinical Decision Support Challenge (‘CDS Challenge’)
- Aug. 6, 2020
- read more
- PRESS RELEASE: Agreement to file a friendly takeover bid initiated by OncoDNA on IntegraGen to acquire all outstanding shares at a price of 2.20€ per share
- July 9, 2020
- read more
- COMMUNIQUÉ DE PRESSE: Accord en vue d’une offre publique d’achat amicale initiée par OncoDNA sur IntegraGen au prix de 2,20€ par action, portant sur la totalité du capital
- July 9, 2020
- read more
- OncoDNA’s personalised cancer profiling tests covered by a new insurer
- Nov. 13, 2019
- read more
- ESMO 2019 ratifies the need to implement genomic analysis in cancer treatment
- Oct. 10, 2019
- read more
- Initiative solidaire : Signature d’un partenariat entre une société spécialisée en médecine de précision dans le cancer et un spécialiste du financement participatif
- Sept. 19, 2019
- read more
- OncoDNA and MD Anderson Cancer Center Madrid sign important collaboration agreement
- Sept. 19, 2019
- read more
- OncoDNA, a pioneering study demonstrates an impact of molecular profiling on the evolution of cancer
- Aug. 20, 2019
- read more
- OncoDNA adds the analysis of germinal DNA, a crucial marker in the management of ovarian, prostate, pancreas and triple-negative breast cancers
- July 29, 2019
- read more
- OncoDNA adds the analysis of germinal DNA, a crucial marker in the management of ovarian, prostate, pancreas and triple-negative breast cancers
- June 30, 2019
- read more
- OncoDNA launches a unique innovative RNA-based NTRK gene fusion molecular profiling solution
- Feb. 5, 2019
- read more
- OncoDNA: Winner of the Healthcare and Life Science category of Deloitte’s 2018 Technology Fast 50 competition.
- Nov. 16, 2018
- read more
- A first in Belgium: A mutuality involved in funding molecular diagnostic tests for cancer
- Nov. 13, 2018
- read more
- Première en Belgique : Intervention d’une mutualité dans le financement des tests de diagnostic moléculaire du cancer.
- Nov. 13, 2018
- read more
- OncoDNA is pleased to announce collaboration in the MDLUX2 program from INC (National Cancer Institute), Molecular Diagnostics Program funded by IBBL (Integrated BioBank of Luxembourg), the Fondation Cancer and the Fondatioun Kriibskr
- Oct. 29, 2018
- read more
- OncoDNA annonce collaborer au lancement de MDLUX2 par l’INC (Institut National du Cancer), programme de diagnostic moléculaire financé par la Fondation Cancer, la Fondatioun Kriibskrank Kanner et IBBL (Integrated BioBank of Luxembourg
- Oct. 29, 2018
- read more
- OncoDNA Signs Distribution Agreement with Gammaray Private Health Services in Turkey and AMS 2000 Trading Impex in Romania
- Oct. 21, 2018
- read more
- OncoDNA announces presentations of clinical study data at ESMO 2018 and new solid tumor analysis product release
- Oct. 17, 2018
- read more

Do you want to share some fresh news with us?

If you have something to say or something to share via our platform, feel free to contact us!

I have a topic to share